Table 2.
Presentation and clinical outcomes of infants infected with SARS-CoV-2 who were born to individuals vaccinated in pregnancy.
| Clinical Characteristics of Infants with COVID-19 | Infants (n = 38) |
|---|---|
| Age at SARS-CoV-2 Infection, average (SD), months | 8.5 (3.0) |
| COVID-19-Related Hospitalizations, n (%) | 0 |
| Symptoms Reported, n (%) | |
| Congestion/rhinorrhea | 33 (86.8) |
| Cough | 25 (65.8) |
| Fever | 22 (57.9) |
| Increased fussiness | 7 (18.4) |
| Parent perception of fatigue | 6 (15.8) |
| Parent perception of reduced appetite | 3 (7.9) |
| Parent perception of difficulty swallowing | 2 (5.3) |
| Parent perception of labored breathing | 2 (5.3) |
| Parent perception of difficulty sleeping | 2 (5.3) |
| Vomiting | 2 (5.3) |
| Diarrhea | 2 (5.3) |
| Rash | 2 (5.3) |
| At-Home Treatments Reported, n (%) | |
| Antipyretics | 18 (47.4) |
| Oral Steroids for wheezing | 2 (5.3) |
| None | 18 (47.4) |
| Testing Modality, number (%) | |
| PCR | 21 (55.3) |
| Rapid Antigen | 15 (39.5) |
| Never tested, but exposed and symptomatic | 2 (5.3) |